130 related articles for article (PubMed ID: 26634784)
1. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
3. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
Shi NQ; Gao W; Xiang B; Qi XR
Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
[TBL] [Abstract][Full Text] [Related]
4. ACPI Conjugated Gold Nanorods as Nanoplatform for Dual Image Guided Activatable Photodynamic and Photothermal Combined Therapy In Vivo.
Qiu WX; Liu LH; Li SY; Lei Q; Luo GF; Zhang XZ
Small; 2017 May; 13(18):. PubMed ID: 28266809
[TBL] [Abstract][Full Text] [Related]
5. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
6. Ratiometric Biosensor for Aggregation-Induced Emission-Guided Precise Photodynamic Therapy.
Han K; Wang SB; Lei Q; Zhu JY; Zhang XZ
ACS Nano; 2015 Oct; 9(10):10268-77. PubMed ID: 26348984
[TBL] [Abstract][Full Text] [Related]
7. A Cell Membrane-Targeting Self-Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback.
Ma W; Sha SN; Chen PL; Yu M; Chen JJ; Huang CB; Yu B; Liu Y; Liu LH; Yu ZQ
Adv Healthc Mater; 2020 Jan; 9(1):e1901100. PubMed ID: 31763796
[TBL] [Abstract][Full Text] [Related]
8. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
9. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
10. Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery.
Cheng H; Zhu JY; Xu XD; Qiu WX; Lei Q; Han K; Cheng YJ; Zhang XZ
ACS Appl Mater Interfaces; 2015 Jul; 7(29):16061-9. PubMed ID: 26161578
[TBL] [Abstract][Full Text] [Related]
11. A ratiometric theranostic probe for tumor targeting therapy and self-therapeutic monitoring.
Li SY; Cheng H; Xie BR; Qiu WX; Song LL; Zhuo RX; Zhang XZ
Biomaterials; 2016 Oct; 104():297-309. PubMed ID: 27475726
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
13. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
14. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
15. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Crisp JL; Savariar EN; Glasgow HL; Ellies LG; Whitney MA; Tsien RY
Mol Cancer Ther; 2014 Jun; 13(6):1514-25. PubMed ID: 24737028
[TBL] [Abstract][Full Text] [Related]
17. Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.
Shi NQ; Qi XR
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10519-10529. PubMed ID: 28290666
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
19. Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.
Ma P; Yu H; Zhang X; Mu H; Chu Y; Ni L; Xing P; Wang Y; Sun K
Pharm Res; 2017 Jan; 34(1):121-135. PubMed ID: 27848167
[TBL] [Abstract][Full Text] [Related]
20. PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo.
Veiman KL; Künnapuu K; Lehto T; Kiisholts K; Pärn K; Langel Ü; Kurrikoff K
J Control Release; 2015 Jul; 209():238-47. PubMed ID: 25935707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
